アラート

GSK (GLAXF)

OTC Markets OTCPK: GLAXF · リアルタイム株価 · USD

25.42

+0.23 (0.91%)

終値時点： Aug 13, 2026, 2:11 PM

0.91% (1D)

買気配	24.29
時価総額	101.82B
売上高（TTM）	33.2B
純利益（TTM）	4.82B
ベータ	0.29
EPS（TTM）	1.59
PER（TTM）	15.99
予想PER	11.55
PBR（TTM）	4.29
PSR（TTM）	3.07
Earnings Date	Oct 28, 2026

売気配	26.08
出来高	150
平均出来高（20日）	729
始値	24.29
前日終値	25.19
当日レンジ	24.29 - 24.29
52週レンジ	18.99 - 31.48
アナリスト	n/a
目標株価	n/a
配当	$0.9 (3.56%)
権利落ち日	2026年8月13日

GLAXFについて

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respirator...

[続きを読む]

業種 Drug Manufacturers - General

セクター Healthcare

IPO日 Jan 5, 2010

従業員数 66,841

上場取引所 OTC Markets OTCPK

ティッカー GLAXF

ウェブサイト https://www.gsk.com

企業情報の全文

業績

2025年のGSKの売上高は32.67Bで、前年の31.38Bから4.11%の増加でした。利益は5.72Bで、121.98%の増加でした。

財務諸表

次回決算発表

GSKの決算発表予定日は Oct 28, 2026, 引け後の予定です。
アナリストの売上高予想は ... アップグレード

ニュース

20時間前 · Insider Monkey

Could GSK plc (GSK)’s Pipeline Acceleration Unlock a New Growth Era?

On July 28, GSK plc (NYSE:GSK) reported its second-quarter financial results, delivering strong core operational performance and showcasing steady commercial momentum. The firm’s total Q2 turnover rea...

1日前 · 24/7 Wall St.

Wave Life Sciences: A $1 Billion RNA-Medicine Bargain Ripe for Pharma Takeover

Wave Life Sciences has lost nearly 70% of its value this year, yet its RNA platform spans obesity, rare liver disease, and genetic disorders in ways that could make it irresistible to the right buyer....

4日前 · Bloomberg

Trump Plans to Sign Order on Splitting Up Combined Measles Shot

(Bloomberg) -- President Donald Trump is expected to sign an executive order Monday that would recommend breaking up the combined measles, mumps and rubella vaccine into three separate shots, accordin...

1週間前 · Zacks

GILD Q2 Earnings Beat on HIV and Trodelvy Growth, Product Sales Outlook Raised

GILD beats Q2 revenue estimates as HIV sales fuel growth, while acquisition charges cause a loss. Higher HIV guidance and pipeline progress support momentum.

1週間前 · Simply Wall St.

GSK (LSE:GSK) Opens Cambridge Research Hub And Teams Up With Relation Therapeutics

GSK (LSE:GSK) plans to establish a new global R&D centre on the Cambridge Biomedical Campus in the UK. The site is expected to accommodate more than 1,000 scientists and support closer work with nearb...

2ページ中1ページ

GSK (GLAXF)

GLAXFについて

業績